KIMBERLY SELIGER: Open Payments
NPI 1316000342 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,679 in 76 payments from 16 companies in 2025. Trend: 2023 $1,789 · 2024 $1,908 · 2025 $1,679
Food & beverage: $1,679
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $348 |
| Galderma Laboratories, L.P. | 15 | $271 |
| ABBVIE INC. | 20 | $261 |
| Regeneron Healthcare Solutions, Inc. | 5 | $175 |
| Janssen Biotech, Inc. | 8 | $172 |
| PFIZER INC. | 3 | $65 |
| Almirall LLC | 2 | $56 |
| Amgen Inc. | 2 | $49 |
| Organon LLC | 2 | $48 |
| LEO Pharma Inc. | 2 | $41 |
Products named: DUPIXENT, NEMLUVIO, SKYRIZI, TREMFYA, RINVOQ, CIBINQO, Seysara, Otezla.
Industry payments across FL — which companies pay providers there.
